Ultrasound-Guided Pulsed Radiofrequency Stimulation of Posterior Tibial Nerve: A Potential Novel Intervention for Recalcitrant Plantar Fasciitis

Abstract Objective To evaluate the therapeutic benefit of ultrasound-guided pulsed radiofrequency (PRF) stimulation at the posterior tibial nerve (PTN) in patients with recalcitrant plantar fasciitis (PF). Design A prospective, randomized, double-blinded, placebo-controlled trial (12-wk follow-up)....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of physical medicine and rehabilitation 2017-05, Vol.98 (5), p.964-970
Hauptverfasser: Wu, Yung-Tsan, MD, Chang, Chih-Ya, MD, Chou, Yu-Ching, PhD, Yeh, Chun-Chang, MD, PhD, Li, Tsung-Ying, MD, Chu, Heng-Yi, MD, Chen, Liang-Cheng, MD, MS
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Objective To evaluate the therapeutic benefit of ultrasound-guided pulsed radiofrequency (PRF) stimulation at the posterior tibial nerve (PTN) in patients with recalcitrant plantar fasciitis (PF). Design A prospective, randomized, double-blinded, placebo-controlled trial (12-wk follow-up). Setting Outpatient local medical center settings. Participants Patients (N=36) with recalcitrant PF underwent randomization, and all were included in the final data analysis. Interventions Patients in the PRF group were treated with 1 dose of ultrasound-guided PRF stimulation at the PTN, and those in the control group received 1 dose of 2% lidocaine, 0.5mL, injected at the PTN under ultrasound guidance. Main Outcome Measures The visual analog scale (first-step and overall pain), American Orthopedic Foot-Ankle Society (AOFAS) ankle-hindfoot scale, and ultrasonographic thickness of the plantar fascia were evaluated at 1, 4, 8, and 12 weeks after treatment. Results Thirty-six patients (20 feet per group) completed the study. The PRF group had a significantly larger improvement in first-step pain, overall pain, and AOFAS score (all P
ISSN:0003-9993
1532-821X
DOI:10.1016/j.apmr.2017.01.016